Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Iradimed ( (IRMD) ).
On December 5, 2025, IRADIMED CORPORATION’s Board of Directors declared a special cash dividend of $0.50 per share, payable on December 30, 2025, to shareholders of record as of December 17, 2025. This decision reflects the company’s strong financial performance, including 17 consecutive quarters of record revenue, and its cash balance of $56.5 million, which exceeds operational needs. The dividend complements the company’s regular quarterly dividend program and highlights its commitment to maximizing shareholder returns.
The most recent analyst rating on (IRMD) stock is a Buy with a $98.00 price target. To see the full list of analyst forecasts on Iradimed stock, see the IRMD Stock Forecast page.
Spark’s Take on IRMD Stock
According to Spark, TipRanks’ AI Analyst, IRMD is a Outperform.
Iradimed’s overall stock score is driven by strong financial performance and positive earnings call insights, indicating robust growth and profitability. The technical analysis supports a positive trend, though the high valuation suggests caution. Regulatory challenges and high operating expenses are potential risks.
To see Spark’s full report on IRMD stock, click here.
More about Iradimed
IRADIMED CORPORATION is a leader in developing innovative MRI-compatible medical devices and products. The company designs, manufactures, markets, and distributes MRI-compatible medical devices, accessories, disposables, and related services. It is the only known provider of a non-magnetic IV infusion pump system specifically designed for safe use during MRI procedures, and it also offers a non-magnetic patient vital signs monitoring system.
Average Trading Volume: 67,455
Technical Sentiment Signal: Buy
Current Market Cap: $1.2B
For a thorough assessment of IRMD stock, go to TipRanks’ Stock Analysis page.